Stay updated on Satralizumab in Generalized Myasthenia Gravis Clinical Trial

Sign up to get notified when there's something new on the Satralizumab in Generalized Myasthenia Gravis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Satralizumab in Generalized Myasthenia Gravis Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    New study locations were added across multiple countries (US, Argentina, Australia, Brazil, Canada, Denmark, France, Germany, Italy, Spain, Japan, China, etc.), expanding geographic coverage for the trial. Concurrently, several location entries were removed and the revision updated to v3.3.3.
    Difference
    0.9%
    Check dated 2025-12-23T22:35:22.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Added a note that publications are automatically filled from PubMed and updated the revision tag from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-25T11:49:22.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Removed the banner about the government funding lapse and NIH operating status; this administrative change does not affect study details or trial data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-18T07:15:55.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    External information links to MedlinePlus Genetics, DailyMed, PubMed, and NIH/NLM pages were removed from the Study Details page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-10-27T19:09:29.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    - Added a government-operations notice about potential delays and current status, plus links for updates. - Updated version to v3.2.0. - Removed the previous v3.1.0 reference.
    Difference
    2%
    Check dated 2025-10-06T05:33:56.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Major update: page now shows Revision: v3.1.0 and removes several drug-safety topics; indicates a content reorganization rather than addition of new substantive material.
    Difference
    0.2%
    Check dated 2025-09-29T03:05:33.000Z thumbnail image

Stay in the know with updates to Satralizumab in Generalized Myasthenia Gravis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Satralizumab in Generalized Myasthenia Gravis Clinical Trial page.